Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
medicinal cannabinoid oil
- Development stage
- Phase 3
- Lead developer
- Zelira Therapeutics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Medicinal cannabinoid oil is a full-spectrum, plant-derived cannabis oil formulation developed by **Zelira Therapeutics** (formerly Zelda Therapeutics). This botanical extract contains a standardized ratio of **delta-9-tetrahydrocannabinol (THC)** and **cannabidiol (CBD)**, along with other minor cannabinoids and terpenes found in the whole cannabis plant. The formulation targets the **endocannabinoid system**, specifically acting as an agonist at **CB1 and CB2 receptors** to modulate pain perception, reduce inflammation, and improve sleep and mood. It was primarily evaluated in a Phase I clinical trial in Australia (ACTRN12617001195303) for patients with chronic non-cancer pain to assess its safety, pharmacokinetics, and potential to reduce opioid dependence. The product is manufactured according to Good Manufacturing Practice (GMP) standards and is compliant with Australian Therapeutic Goods Administration (TGA) regulations.
- Brand names
- ZenivolHOPE
- Other names
- Zelda medicinal cannabis oilfull-spectrum cannabis oil
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)PPARG (Peroxisome proliferator-activated receptor gamma)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on medicinal cannabinoid oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on medicinal cannabinoid oil.